Legg Mason Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Legg Mason Asset Management's BIIB Position: Q1 2021 in Review
Legg Mason Asset Management sold out of Biogen (BIIB) in Q1 2021, closing a stake of 1,662 shares — an estimated $407K sold.
Legg Mason Asset Management first reported a position in BIIB in Q4 2014 and held it in 24 quarters. The position peaked at $1.56M in Q1 2015. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.
- Legg Mason Asset Management reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
- Legg Mason Asset Management sold 1,662 Biogen shares in Q1 2021, an estimated $407K.
- Legg Mason Asset Management first reported a position in Biogen in Q4 2014 and held it in 24 quarters.
- Legg Mason Asset Management's Biogen position peaked at $1.56M in Q1 2015.
- 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.
Based on Legg Mason Asset Management's 13F filing for Q1 2021, filed 13 May 2021.